TABLE 2.

Pairwise AmpFire and Xpert results, categorised hierarchically according to HPV risk groups, Rwanda, June 2018 - June 2019.

Xpert AmpFire	HPV16	HPV18/45	HPV31/33/35/52/58	HPV51/59 + HPV39/56/66/68	Negative	Total
HPV16	35	2	5	4	7	53
Row %	66.0	3.8	9.4	7.5	13.2	100.0
Column %	97.2	7.1	8.5	19.0	5.0	18.7
HPV18/45	0	24	3	1	2	30
Row %	0.0	80.0	10.0	3.3	6.7	100.0
Column %	0.0	85.7	5.1	4.8	1.4	10.6
HPV31/33/35/52/58	0	0	44	0	8	52
Row %	0.0	0.0	84.6	0.0	15.4	100.0
Column %	0.0	0.0	74.6	0.0	5.8	18.4
HPV51/59 + HPV39/56/66/68	0	0	0	16	5	21
Row %	0.0	0.0	0.0	76.2	23.8	100.0
Column %	0.0	0.0	0.0	76.2	3.6	7.4
Negative	1	2	7	0	117	127
Row %	0.8	1.6	5.5	0.0	92.1	100.0
Column %	2.8	7.1	11.9	0.0	84.2	44.9
Total	36	28	59	21	139	283
Row %	12.7	9.9	20.8	7.4	49.1	100.0
Column %	100.0	100.0	100.0	100.0	100.0	100.0

Note: N = 283 women living with HIV undergoing colposcopy. Data in bold are concordant HPV risk group results.

Unweighted kappa = 0.77 (95% confidence interval = 0.70–0.85).

HPV, human papillomavirus.